Corporate travel disruptor Navan soared into the public markets Thursday, raising a staggering $923 million in its much-anticipated initial public offering (IPO)—a bold move in a year marked by market caution and limited listings.

The company, known for reinventing how businesses handle travel and expense management, priced 36.9 million shares at $25 each, the midpoint of its expected range between $24 and $26 per share. According to Wednesday’s filing, 30 million shares were sold directly by Navan, while 6.9 million shares came from existing investors cashing in on the offering.

Navan officially began trading under the ticker symbol “NAVN” on the Nasdaq, and the offering is expected to close Friday.

A Tech Unicorn’s Leap from Private to Public

The Silicon Valley–based company is backed by venture capital titans including Lightspeed Ventures, Andreessen Horowitz, and Zev Ventures, and serves more than 10,000 active business users worldwide.

In its filing with the U.S. Securities and Exchange Commission, Navan described itself as an “all-in-one” corporate travel, payments, and expense platform, built to simplify and automate global business operations through artificial intelligence.

Its technology suite includes:

• Navan Cloud – providing comprehensive global travel inventory.

• Navan Cognition – an AI-driven engine that streamlines bookings and expense reports.

• Ava – a virtual assistant that learns and anticipates user needs.

“Navan challenges the status quo by centering users, customers, and suppliers within a unified global platform,” the company said in its SEC filing. “With AI-powered booking and policy integration, users save time while companies maintain compliance and visibility.”

Timing the Market with Precision

Navan’s IPO stands out as one of the few high-profile listings amid a sluggish IPO environment. A lingering government shutdown has stalled the U.S. Securities and Exchange Commission’s review of many filings, freezing the IPO pipeline for several startups eager to go public.

Despite the slowdown, Navan joins MapLight Therapeutics, which raised $251 million earlier this week, and Medline, the private equity-backed medical supplier that also filed for a public debut on Tuesday — signaling that investor appetite for strong tech-driven firms may be rekindling.

Legal Titans Behind the Offering

Navan’s IPO was shepherded by Cooley LLP, whose team included John McKenna, Rachel Proffitt, Jon Avina, Milson Yu, and Jean Park. The underwriting syndicate was represented by Fenwick & West LLP, with Ran Ben-Tzur, Cynthia Hess, Jennifer Hitchcock, and Aman Singh leading the advisory team.

As Navan takes its first steps as a public company, its $923 million debut not only redefines the landscape for corporate travel technology but also rekindles hope for the 2025 IPO market—showing that, even amid uncertainty, innovation still finds a runway.